XML 15 R5.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Series E Cumulative Redeemable Preferred Stock
Preferred Stock
Series E Cumulative Redeemable Preferred Stock
Cumulative dividends and distributions
Series E Cumulative Redeemable Preferred Stock
Series F Cumulative Redeemable Preferred Stock
Preferred Stock
Series F Cumulative Redeemable Preferred Stock
Cumulative dividends and distributions
Series F Cumulative Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings
Cumulative dividends and distributions
Noncontrolling Interest in Consolidated Joint Venture
Total
Beginning Balance at Dec. 31, 2017 $ 115,000     $ 75,000     $ 2,253 $ 2,679,221 $ 932,277 $ (1,270,013) $ 48,440 $ 2,582,178
Beginning Balance (in shares) at Dec. 31, 2017 4,600,000     3,000,000     225,321,660          
Increase (Decrease) in Stockholders' Equity                        
Amortization of deferred stock compensation               2,113       2,113
Issuance of restricted common stock, net             $ 3 (4,235)       (4,232)
Issuance of restricted common stock, net (in shares)             297,013          
Forfeiture of restricted common stock (in shares)             (3,961)          
Common stock distributions and distributions payable                   (11,281)   (11,281)
Preferred stock dividends and dividends payable   $ (1,998) $ (1,998)   $ (1,209) $ (1,209)            
Distributions to noncontrolling interest                     (1,169) (1,169)
Net income                 36,016   2,439 38,455
Ending Balance at Mar. 31, 2018 $ 115,000     $ 75,000     $ 2,256 2,677,099 968,293 (1,284,501) 49,710 2,602,857
Ending Balance (in shares) at Mar. 31, 2018 4,600,000     3,000,000     225,614,712          
Beginning Balance at Dec. 31, 2018 $ 115,000     $ 75,000     $ 2,282 2,728,684 1,182,722 (1,440,202) 47,685 2,711,171
Beginning Balance (in shares) at Dec. 31, 2018 4,600,000     3,000,000     228,246,247          
Increase (Decrease) in Stockholders' Equity                        
Amortization of deferred stock compensation               2,221       2,221
Issuance of restricted common stock, net             $ 4 (4,439)       (4,435)
Issuance of restricted common stock, net (in shares)             345,132          
Forfeiture of restricted common stock (in shares)             (3,932)          
Common stock distributions and distributions payable                   (11,429)   (11,429)
Preferred stock dividends and dividends payable   $ (1,998) $ (1,998)   $ (1,209) $ (1,209)            
Distributions to noncontrolling interest                     (1,950) (1,950)
Net income                 16,317   1,599 17,916
Ending Balance at Mar. 31, 2019 $ 115,000     $ 75,000     $ 2,286 $ 2,726,466 $ 1,199,039 $ (1,454,838) $ 47,334 $ 2,710,287
Ending Balance (in shares) at Mar. 31, 2019 4,600,000     3,000,000     228,587,447